Read More Pharma Industry News AbbVie’s SKYRIZI wins FDA approval for ulcerative colitis treatment The U.S. Food and Drug Administration (FDA) has approved SKYRIZI (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor developed by AbbVie,… byPallavi MadhirajuJune 19, 2024